Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruinsma

Showing results (551-560 of 963) with videos related to

Pageof 97
Sort By:
Clinicoeconomics and Outcomes Research : CEOR|February 13, 2015
Estimating the real world daily usage and cost for exenatide twice daily and liraglutide in Germany, the Netherlands, and the UK based on volumes dispensed by pharmaciesAmanda L McDonell, Urpo Kiiskinen, Danielle C Zammit, et al.
Clinical Biomechanics (Bristol, Avon)|June 17, 2025
Mobility metrics in individuals with and without an indication for knee arthroplasty: An explorative analysisF J Bruning, C J Ensink, K C Defoort, et al.
The American Surgeon|December 23, 2025
Outcomes of Colorectal Resections in Renal Transplant Patients: A Systematic Review and Meta-AnalysisMohammed Elfaki, Benjamin M Mac Curtain, Josh Bruinsma, et al.
The Journal of Biological Chemistry|April 5, 2018
Small molecules that inhibit the late stage of Munc13-4-dependent secretory granule exocytosis in mast cellsStephen Bruinsma, Declan J James, Melanie Quintana Serrano, et al.
Annals of the Rheumatic Diseases|May 20, 2005
Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitisJ C van Denderen, M van der Paardt, M T Nurmohamed, et al.
Nature|March 20, 2025
End-to-end data-driven weather predictionAnna Allen, Stratis Markou, Will Tebbutt, et al.
Annals of the Rheumatic Diseases|October 5, 2013
Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitisAlper M van Sijl, Izhar C van Eijk, Mike J L Peters, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 5, 2019
Implementation of a specific safety check is associated with lower postoperative mortality in cardiac surgeryAlexander J Spanjersberg, Jan Paul Ottervanger, Arno P Nierich, et al.
Scandinavian Journal of Rheumatology|November 2, 2021
Disease activity in women with ankylosing spondylitis remains higher under Tumour Necrosis Factor inhibitor treatment than in men: a five-year observational studyT Rusman, M T Nurmohamed, S Hoekstra, et al.
Journal of Clinical Microbiology|May 1, 1997
Characterization of an immunoreactive protein from the agent of human granulocytic ehrlichiosisC P Kolbert, E S Bruinsma, A S Abdulkarim, et al.
Pageof 97

Showing results (551-560 of 963) with videos related to

Sort By:
Pageof 97
Clinicoeconomics and Outcomes Research : CEOR|February 13, 2015
Estimating the real world daily usage and cost for exenatide twice daily and liraglutide in Germany, the Netherlands, and the UK based on volumes dispensed by pharmaciesAmanda L McDonell, Urpo Kiiskinen, Danielle C Zammit, et al.
Clinical Biomechanics (Bristol, Avon)|June 17, 2025
Mobility metrics in individuals with and without an indication for knee arthroplasty: An explorative analysisF J Bruning, C J Ensink, K C Defoort, et al.
The American Surgeon|December 23, 2025
Outcomes of Colorectal Resections in Renal Transplant Patients: A Systematic Review and Meta-AnalysisMohammed Elfaki, Benjamin M Mac Curtain, Josh Bruinsma, et al.
The Journal of Biological Chemistry|April 5, 2018
Small molecules that inhibit the late stage of Munc13-4-dependent secretory granule exocytosis in mast cellsStephen Bruinsma, Declan J James, Melanie Quintana Serrano, et al.
Annals of the Rheumatic Diseases|May 20, 2005
Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitisJ C van Denderen, M van der Paardt, M T Nurmohamed, et al.
Nature|March 20, 2025
End-to-end data-driven weather predictionAnna Allen, Stratis Markou, Will Tebbutt, et al.
Annals of the Rheumatic Diseases|October 5, 2013
Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitisAlper M van Sijl, Izhar C van Eijk, Mike J L Peters, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 5, 2019
Implementation of a specific safety check is associated with lower postoperative mortality in cardiac surgeryAlexander J Spanjersberg, Jan Paul Ottervanger, Arno P Nierich, et al.
Scandinavian Journal of Rheumatology|November 2, 2021
Disease activity in women with ankylosing spondylitis remains higher under Tumour Necrosis Factor inhibitor treatment than in men: a five-year observational studyT Rusman, M T Nurmohamed, S Hoekstra, et al.
Journal of Clinical Microbiology|May 1, 1997
Characterization of an immunoreactive protein from the agent of human granulocytic ehrlichiosisC P Kolbert, E S Bruinsma, A S Abdulkarim, et al.
Pageof 97